Ligand Pharmaceuticals Future Growth
How is Ligand Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Future Growth Score
3/6Future Growth Score 3/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
120.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 164 | N/A | 74 | N/A | 1 |
12/31/2024 | 170 | 29 | 62 | N/A | 3 |
12/31/2023 | 124 | 4 | 26 | N/A | 5 |
9/30/2022 | 242 | -21 | 95 | 112 | N/A |
6/30/2022 | 240 | -8 | 97 | 112 | N/A |
3/31/2022 | 268 | 24 | 110 | 120 | N/A |
12/31/2021 | 277 | 57 | 71 | 79 | N/A |
9/30/2021 | 275 | 68 | 45 | 52 | N/A |
6/30/2021 | 252 | 48 | 37 | 44 | N/A |
3/31/2021 | 208 | 39 | 42 | 48 | N/A |
12/31/2020 | 186 | -3 | 51 | 55 | N/A |
9/30/2020 | 143 | -16 | 41 | 47 | N/A |
6/30/2020 | 126 | -25 | 24 | 28 | N/A |
3/31/2020 | 110 | -61 | -60 | -58 | N/A |
12/31/2019 | 120 | 629 | 781 | -29 | N/A |
9/30/2019 | 153 | 594 | 812 | 11 | N/A |
6/30/2019 | 174 | 677 | 846 | 44 | N/A |
3/31/2019 | 239 | 764 | 980 | 179 | N/A |
12/31/2018 | 251 | 143 | 183 | 194 | N/A |
9/30/2018 | 242 | 179 | 198 | 193 | N/A |
6/30/2018 | 230 | 120 | 196 | 193 | N/A |
3/31/2018 | 168 | 53 | 135 | 130 | N/A |
12/31/2017 | 141 | 13 | 93 | 89 | N/A |
9/30/2017 | 129 | 16 | 78 | 78 | N/A |
6/30/2017 | 117 | 9 | 71 | 69 | N/A |
3/31/2017 | 109 | -3 | 50 | 69 | N/A |
12/31/2016 | 109 | -2 | 41 | 61 | N/A |
9/30/2016 | 92 | 7 | 36 | 56 | N/A |
6/30/2016 | 88 | 205 | N/A | 48 | N/A |
3/31/2016 | 87 | 235 | N/A | 47 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LGND is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).
Earnings vs Market: LGND is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: LGND is expected to become profitable in the next 3 years.
Revenue vs Market: LGND's revenue (3.6% per year) is forecast to grow slower than the US market (7.1% per year).
High Growth Revenue: LGND's revenue (3.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LGND's Return on Equity is forecast to be high in 3 years time